Navigation Links
U of T research finds glycine could be key to REM Sleep Behavior Disorder
Date:3/27/2008

TORONTO, ON. There is new promise on the horizon for those who suffer from REM Sleep Behaviour Disorder (RBD) according to researchers at the University of Toronto.

RDB, a neurological disorder that causes violent twitches and muscle contractions during rapid eye-movement (REM) sleep, can lead to serious injuries. John Peever, Assistant Professor at the University of Toronto, discovered that an inhibitory brain chemical called glycine is responsible for actively suppressing muscle twitches in REM sleep. Deficiency in glycine levels in the brain cells that control muscles (motoneurons) was found to cause the violent muscle contractions that mimic the primary symptom of RBD.

This study shows the mechanism that suppresses muscles twitches in REM sleep and this will lead to better treatments and potential cures for this disorder, says Peever. Treating REM sleep disorder may have much broader implications, since within five to eight years of being diagnosed with this disorder, 60-80% of individuals eventually develop Parkinsons disease.


'/>"/>

Contact: Christa Poole
christa.poole@utoronto.ca
University of Toronto
Source:Eurekalert

Page: 1

Related medicine news :

1. UC Irvine researchers present latest findings at emergency medicine forum
2. Target Data Research Sponsors Forgotten Citizens Who Are in Need of Public Guardianship To Support and Manage Their Healthcare and Personal Needs
3. Researchers urge ethics guidelines for human-genome research
4. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
5. MarketResearch.com Announces Distribution of Wireless Healthcare Research
6. MarketResearch.com Announces Distribution of CarbonFree Research
7. OHSU Cancer Institute researchers identify new approach to help control drug resistance in leukemia
8. FSU researchers mutant proteins could lead to new treatment for heart disease
9. Source Endurance and So High Sports Announce Research Alliance for Physiology and Human Performance
10. Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions
11. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 2016 , ... Over 40 athletic trainer’s (ATs) and athletic training students (ATSs) ... “Hike to Harrisburg” advocacy day. The annual lobbying effort is a collaboration between ... The goal for the day was to educate the elected legislators and the public ...
(Date:5/4/2016)... ... May 04, 2016 , ... Vasont Systems, a ... Integrator (VUI) extension supports the latest release of Adobe FrameMaker, Release 2015. The ... the process of creating, editing and storing XML. , The VUI ...
(Date:5/3/2016)... , ... May 04, 2016 , ... ... cancer. That message is reaching the global health community through expanding activities that ... burden of cancer in the resource-limited countries. , In support of ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... patients report dissatisfaction with numerous issues related to medical care in the hospital ... and poor bedside manner from hospital staff. Commenting on this article, the founder ...
(Date:5/3/2016)... ... ... Sue Desmond-Hellmann, chief executive officer of the Bill & Melinda Gates Foundation, ... in her keynote address at Georgia State University’s spring commencement on Saturday, ... experience as a scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s efforts to ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... Global and Chinese Surgical ... overview of the industry that covers definition, applications ... report explores into the international and Chinese players ... Surgical Mesh market spread across 150 pages providing ... is available at http://www.reportsnreports.com/reports/470569-global-and-chinese-surgical-mesh-industry-2016-market-research-report.html . ...
(Date:5/2/2016)...  Deerfield announced today it led the $44.5 ... Graybug Vision is an early stage pharmaceutical company ... for ocular diseases including wet age-related macular degeneration ... developed at Johns Hopkins University and has been ... Graybug Vision is developing ophthalmology products enabling ...
(Date:4/29/2016)... Calif. , April 29, 2016  In ... is projected to shift from systems dependent on ... all types of modality CRT Medical monitors and ... there are a host of foreseeable benefits to ... concern; will existing modalities have to be replaced ...
Breaking Medicine Technology: